VERGENIX™ FLOWABLE GEL

The Ideal Regenerative Building Block for Wound Management

Vergenix™FG IS A RECOMBINANT HUMAN COLLAGEN
MATRIX FOR THE MANAGEMENT OF CHRONIC AND ACUTE WOUNDS

Produced via bioengineered
plant-based technology

Identical to type I collagen
produced by the human body

3D scaffold for deep/
irregular wound shapes

A single application
is sufficient

Promotes new
tissue formation

Faster wound
healing

Clinically significant wound closure in

72%

 of patients by week 16 following a
single application

Doctor consulting with patient Knee problems Physical therapy concept

Physician testimonial

“Vegrenix™FG is the most effective filler I used so far.
It is easy to use, and in my surgical practice helps me
in addressing problems with loss of substance after
debridement or bone and joint removal for osteomyelitis.
In two words: IT WORKS”

Prof. Alberto Piaggesi
Director, Diabetic Foot Section, University of Pisa,
Member of Board of Directors of Diabetic Foot Study
Group of European Association. Honorary Secretary – EWMA

 LATEST NEWS & EVENTS

New Vergenix™FG clinical results now published

 July 2020

Study by Iacopi E et al from the University Hospital in Pisa, Italy shows increased healing rate and shortened healing time in patients with post-surgical diabetic foot wounds treated with Vergenix™ FG.

 

Full abstract 

Vergenix™FG now available in Ukraine 

October 2020

Patients in Ukraine will now have access to Vergenix™FG.

 

 

 

 

 

 

For more details, contact us

EWMA 2020

 

November 2020

Prof. Nikolaos Tentolouris from Laikο General Hospital of Athens, Greece, will present a poster titled “Recombinant human collagen-based flowable matrix for chronic wound management: a case study series”.

EWMA 2020 Virtual

CONTACT US 

4 Oppenheimer St., P.O.B 4132 Rehovot, 7670104 ,Israel

Skip to toolbar